entertainment -WSS

entertainment

author：fashion 2025-09-06 04:50:55 - browse：892

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Lilly’s weekly insulin works as well as daily products, new studies show

hotspot

knowledge

WSS

Hottest summer in 2,000 years puts focus on extreme heat, health

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

In Spain, a hospital brews its own CAR

The United States must get value

The United States must get value

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

focus

entertainment

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WuXi Biologics beefs up its lobbying operation

Guidelines to prevent youth baseball injuries need more muscle

What STAT readers think about the FDA and patient advocacy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CRISPR gene editing developments we’re watching in 2024

Drug repurposing or repositioning? The language matters

Novo Nordisk testing Wegovy against alcohol

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In Spain, a hospital brews its own CAR

Wikipedia

Fertility clinic egg and embryo storage is a disaster

Prime Medicine, Myeloid Therapeutics clash over genome

Galapagos to make CAR

The White House hikes tariffs on plastic syringes made in China

STAT reporters are Pulitzer Prize finalists for investigative reporting

Fertility clinic egg and embryo storage is a disaster

hotspot

knowledge

hotspot

Wikipedia